Abstract
The term preleukemia introduced by Hamilton-Paterson in 1949 and Block et al. in 1953 described any syndrome which precedes the onset of acute leukemia but in which the criteria for the diagnosis of acute leukemia are not fulfilled. Later preleukemia was considered as peripheral pancytopenia with hyperplastic bone marrow due to ineffective hemopoiesis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Applebaum FR, Storb R, Ramberg RE, et al. (1984) Allogeneic marrow transplantation in the treatment of preleukemia. Ann Intern Med 100: 689–693
Bagby GC Jr, Gabourel JD, Linman JW (1980) Glucocorticoid therapy in the preleukemic syndrome (hemopoietic dysplasia). Identification of responsive patients using in vitro techniques. Ann Intern Med 92: 55–58
Bhadhuri S, Kubanek B, Heit W, et al. (1979) A case of preleukemia - reconstitution of normal marrow function after bone marrow transplantation ( BMT) from identical twins. Blut 38: 145–149
Bennett JM, Catovsky D, Daniel MT, et al. (1982) Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199
Bloch A (1984) Induced cell differentiation in cancer therapy. Can Treatm Rep 68: 199–205
Block M, Jacobson LO, Bethard WF (1953) Preleukemic acute human leukemia. JAMA 152: 1018–1028
Fearon ER, Burke PJ, Schiffer CA, et al. (1986) Differentiation of leukemic cells to polymorpho-nuclear leukocytes in patients with acute nonlymphatic leukemia. N Engl J Med 315: 15–24
Francis GE, Guimaraes JETE, Berney JJ, Wing MA (1985) Synergistic interaction between differ-entiation inducers and DNA synthesis inhibitors: a new approach to differentiation induction in myelodysplasia and acute myeloid leukemia. Leuk Res 9: 573–581
Hamilton-Paterson JL (1949) Preleukaemic anaemia. Acta Haematol (Basel) 2: 309–316
Heimpel H, Hoelzer D (1982) Grenzfälle der Behandlung akuter Leukämien In: Scheurlen PG, Pees HW (eds) Aktuelle Therapie bösartiger Blutkrankheiten. Springer, Berlin Heidelberg New York, pp 58–68
Hoelzer D, Kurrle E, Schmücker H, Harriss EB (1977) Evidence for differentiation of human leukaemic blood cells in diffusion chamber culture. Blood 49: 729–744
Hoelzer G, Ganser A, Heimpel H (1984) “Atypical” leukemias: preleukemia, smoldering leukemia and hypoplastic leukemia. Recent Results Cancer Res 93: 69–101
Hoelzer D, Ganser A, Schneider W, Heimpel H (1985) Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes. Semin Oncol [Suppl 2] 12: 208–211
Mufti GJ, Stevens JR, Oscier DG, et al. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 59: 425–433
Powell B, Capizzi R, Muss H, et al. (1986) Low dose Ara-C (LoDAC) treatment of acute nonlymphocytic leukemia (ANNL) and myelodysplastic syndromes ( MDS ). Proc Am Soc Clin Oncol 5: 166
Sachs L (1978) Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia. Nature 274: 535
Schlick E, Ruscetti FW (1986) In vivo induction of terminal differentiation of malignant myelo-poietic progenitor cells by CSF-inducing biological response modifiers. Blood 67: 980–987
Swanson G, Picozzi V, Morgan R, et al. (1986) Responses of hemopoietic precursors to 13-cis reti-noic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes. Blood 67: 1154–1161
Teerenhovi L, Lintula R (1986) Natural course of myelodysplastic syndromes–Helsinki experi-ence. Scand J Haematol [Suppl 45] 36: 102–106
Todd WM, Pierre RV (1986) Pre-leukemia: a long-term prospective study of 326 patients. Scand J Haematol [Suppl 45] 36: 114–120
Tricot G, Bogaerts MA, Verwilghen RL (1986 a) Treatment of patients with myelodysplastic syndromes: a review. Scand J Haematol [Suppl 1] 36: 121–127
Tricot G, Vlietinck R, Verwilghen RL (1986b) Prognostic factors in the myelodysplastic syndromes: a review. Scand J Haematol [Suppl 1] 36: 107–113
Yunis JJ, Rydell RE, Oken MM, et al. (1986) Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 67: 1721–1730
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Hoelzer, D. (1988). Cytobiology and Clinical Findings of Myelodysplastic Syndromes. In: Grundmann, E., Beck, L. (eds) Minimal Neoplasia. Recent Results in Cancer Research, vol 106. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83245-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-83245-1_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83247-5
Online ISBN: 978-3-642-83245-1
eBook Packages: Springer Book Archive